Inventor · disambiguated record
Dongsik Park
Also filed as: PARK DONGSIK
6 granted patents·5 pending applications·1 citations·filing 2014–2023
63Inventor score
Top patents by PatentIndex Score
11 records- 0170US11858937B2Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitorsQURIENT CO LTD·Filed 2019·Granted Jan 2, 2024·1 cites·47 claims
- 0260US2025340537A1Pharmaceutically active compounds, compositions, and methods for modulating pendrinARBORMED CO LTD·Filed 2023·Application pending·0 cites
- 0357US2025388582A1Novel bicyclic heteroaryl compound and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0454US2024343732A1Compounds for degradation of cyclin-dependent kinase 7(cdk7)QURIENT CO LTD·Filed 2022·Application pending·0 cites
- 0553US2025263413A1Compounds having cyclin-dependent kinase(cdk)-inhibitory functionQURIENT CO LTD·Filed 2021·Application pending·0 cites
- 0640US12162858B2Quinoline derivatives as inhibitors of AXL/MER RTK and CSF1RQURIENT CO LTD·Filed 2019·Granted Dec 10, 2024·0 cites·23 claims
- 0739US11945822B2Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinaseQURIENT CO LTD·Filed 2019·Granted Apr 2, 2024·0 cites·20 claims
- 0838US2016185774A1Anti-Infective CompoundsPASTEUR INSTITUT KOREA·Filed 2014·Application pending·0 cites
- 0929US10934274B2Quinoline derivatives as TAM RTK inhibitorsQURIENT CO LTD·Filed 2016·Granted Mar 2, 2021·0 cites·16 claims
- 1026US11447486B22-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitorsPASTEUR INSTITUT KOREA·Filed 2015·Granted Sep 20, 2022·0 cites·19 claims
- 1126US9809602B2Compounds for treating viral infectionsPASTEUR INSTITUT KOREA·Filed 2015·Granted Nov 7, 2017·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Dongsik Park files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →